Cancer de prostata - Tot ce trebuie sa stii | Cancer

Prostate cancer survival rate gleason score 9

Conținutul

    Source: Acta Medica Transilvanica.

    prostate cancer survival rate gleason score 9

    The purpose of this study is represented by the clinical evaluation of the effectiveness of open radical retropubic prostatectomy with bilateral ilio-obturator lymph node dissection in patients with prostate cancer. We studied a group of patients who underwent open radical retropubic prostatectomy for prostate cancer in localized stage between January - February The average age of patients was Preoperative PSA level was between 2.

    prostate cancer survival rate gleason score 9

    Preoperative tumour stage was T1-T2 in After puncture prostate biopsy, Gleason score revealed that The research has shown that open radical retropubic prostatectomy is an effective treatment with curative intent in the carefully selected patients with localized prostate cancer.

    This surgical procedure provides good oncological outcomes with long life expectancy, good quality of life for patients and a low incidence of complications.

    prostate cancer survival rate gleason score 9

    Copyright of Acta Medica Transilvanica is the property of Acta Medica Transilvanica and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.

    However, users may print, download, or email articles for individual use.

    prostate cancer survival rate gleason score 9

    This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.

    prostate cancer survival rate gleason score 9

    Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, prostate cancer survival rate gleason score 9 use. However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.

    prostate cancer survival rate gleason score 9